Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) said its open offer of new stock brought in £1.2 million, bringing the total proceeds from this and the company’s share subscription placing to £11.9 million. The cash injection will be used to continue the exciting work on its SCIB 1/SCIB + development programmes. Last month, researchers shared highly encouraging results from a group of hard-to-treat melanoma patients. The new investment will also be deployed to keep up the clinical momentum with its Modi-1 programme.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com